Long-term safety and clinical outcomes of pz-cel gene therapy in a single patient with recessive dystrophic epidermolysis bullosa: A 12-year case report

Zevaskyn (prademagene zamikeracel) - Abeona Therap

Ricardo Villanueva Gaona* 1; Ashwini Pai 2; Amanda Truesdale 2; Sarah Abdelwahab 2; James Gow 2; Jean Tang 1

May 18, 2026